TAILORx Update: Refinement of Risk & Benefit : Oncology Times
An abstract is unavailable.
Related Articles
Case Study4
Wolters Kluwer (“we” or “us”) wants to inform you about the ways we process your personal information. In this Privacy & Cookie Notice we explain…
An Assortment of Journal Abstracts to Enhance Oncology Care : Oncology Times
An abstract is unavailable.
Patient-Matched Tumor-Normal Sequencing
During our combined 35 years working to advance diagnostic capabilities for cancer—as a pathologist and as a bioinformatician, respectively—we’ve had the opportunity to help build…
A Look at Poor Outcomes in Triple-Class Exposed Multiple… : Oncology Times
An abstract is unavailable.